Results 51 to 60 of about 894 (172)

PBTCA和HEDP低温条件下碳酸钙阻垢性能评价

open access: yesGongye shui chuli, 2018
通过静态阻垢试验研究了PBTCA和HEDP在低温条件下(2~15℃)的阻碳酸钙垢性能。结果表明: PBTCA和HEDP在2~15℃下的阻碳酸钙垢性能良好。初始钙离子+碱度对PBTCA和HEDP的阻垢性能影响较大,当钙离子+碱度从(500+600) mg/L提高至(800+800) mg/L时,PBTCA和HEDP的阻垢率从100%分别降至65%、60%。PO43-、Zn2+和浊度等的存在对PBTCA和HEDP阻垢效果的影响较小。
楼琼慧   +4 more
doaj   +2 more sources

Penetration depth of different final irrigants into the root canal dentinal tubules after bypassing a separated instrument in the apical third – An in vitro confocal microscopic study

open access: yesEndodontology
Aim: The aim of the study was to evaluate and compare the depth of penetration of 0.1% Rhodamine B labeled 17% ethylenediaminetetraacetic acid (EDTA), 0.2% chitosan, and 18% 1-Hydroxyethylidene-1,1-diphosphonic acid (HEDP) root canal irrigants into the ...
Aathira Vijay   +5 more
doaj   +1 more source

Development of Tunable Materials From Well‐Defined Alendronic Acid Functionalized Polyacrylamide: An Opportunity for Actinide Decontamination

open access: yesJournal of Polymer Science, Volume 64, Issue 6, Page 1431-1443, 15 March 2026.
Alendronate‐based copolymers for Nd and Ce recovery. ABSTRACT Bisphosphonic acid groups are emerging as promising functionalities for actinide decontamination, due to their high density of chelating sites. However, the chemistry of bisphosphonate (in particular alendronate) materials remains complex and underexplored.
Vincent Darcos   +7 more
wiley   +1 more source

Influence of heterometallic Ge(IV) – 3d-metals complexes on microbial rhamnosidase, galactosidase and protease activity [PDF]

open access: yesThe Ukrainian Biochemical Journal
In recent years, the attention of researchers has been attracted by coordination compounds of germanium with various bioligands, which may be used both as activator or inhibitor of enzymes.
O. V. Gudzenko   +5 more
doaj   +1 more source

Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

open access: yesWorld Journal of Nuclear Medicine, 2018
188Rhenium-hydroxyethylidene-1,1-diphosphonate (188Re-HEDP) is a clinically established radiopharmaceutical for bone pain palliation of patients with metastatic bone cancer.
Ajit Shinto   +10 more
doaj   +1 more source

Use Of The HEDP For The Inhibition Of The Tartar Of Ground Waters

open access: yesEnergy Procedia, 2012
AbstractThe earthy waters of Hamma and Negrine are characterized by the presence of a very large quantity of calcium carbonate on surfaces of the domestic facilities and industrial during their circulation. This deposit has very serious technical consequences. The study of water of the two sources Hamma and Negrine showed that this water is furring and
Boulahlib-Bendaoud, Y   +1 more
openaire   +1 more source

Influence of Technological and Environmental Factors on the Major Ion Composition in Cooling Water Discharges of a Nuclear Power Plant

open access: yesEnergy Science &Engineering, Volume 14, Issue 3, Page 1567-1583, March 2026.
Statistical modelling and grey water footprint analysis revealed how technological and environmental factors shape the major ion composition of cooling water discharges from a nuclear power plant. Findings highlight that while ion concentrations increase post‐discharge, they remain within regulatory limits, ensuring minimal ecological impact.
Olha Biedunkova   +3 more
wiley   +1 more source

Bone Metastasis: Molecular Mechanisms, Clinical Management, and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
This figure emphasizes current understanding of the regulatory networks, approach of diagnose, available preclinical models and clinical management of bone metastasis. to guide future therapeutic development. A deep understanding of these aspects enables the prevention of bone metastasis and the implementation of effective therapeutic strategies ...
Jingyuan Wen   +5 more
wiley   +1 more source

Dosimetry and Therapeutic Ratios for Rhenium-186 HEDP

open access: yesISRN Molecular Imaging, 2013
Rhenium-186 (Re-186) is a β-emitting radionuclide. Emitted β-particles have ranges up to 4.5 mm in tissue, capable of delivering high doses to skeletal regions of high Re-186 concentrations while sparing adjacent radiosensitive regions and thus making the irradiation well tolerated for the patient.
Maria Argyrou   +3 more
openaire   +1 more source

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

open access: yesChemBioChem, Volume 27, Issue 1, January 2026.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy